Characterization of rifampicin-resistant Mycobacterium tuberculosis in Taiwan
- 1 March 2003
- journal article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 52 (3) , 239-245
- https://doi.org/10.1099/jmm.0.05045-0
Abstract
Sixty-three rifampicin-resistant (Rifr) isolates of Mycobacterium tuberculosis from Kaohsiung, Taiwan, were analysed for mutations in the core region (69 bp, codons 511–533) of the rpoB gene. Some 84.1 % (53/63) of the resistant isolates showed mutations in this region, especially in codons 531 (41.5 %), 526 (18.9 %), 516 (15.1 %) and 533 (7.5 %). Five novel alleles of a total of 16 different types of mutations were identified in Rifr isolates. Ten Rifr isolates (15.9 %) exhibited no mutations in the core region of rpoB. Also, they did not show mutations in another 365 bp fragment (codons 99–220) of rpoB. The agar proportion method was used to determine the relationship between the degree of rifampicin resistance and alterations in the core region of rpoB. The results revealed that the mean MIC was 92.38 μg ml−1 for the 53 isolates with a mutation in the core region, whereas the mean MIC of the other 10 isolates without mutations was only 24.8 μg ml−1. This indicates that the isolates with mutations in the core region had higher levels of resistance than those without mutations in this region. IS6110 restriction fragment length polymorphism (RFLP) was used for typing of 55 Rifr M. tuberculosis isolates. Isolates contained two to 19 copies of IS6110, with sizes ranging from 600 to 16 000 bp. The majority (85 %) contained six to 16 copies. No strains lacking IS6110 were found. A total of 54 of 55 RFLP types were defined at the 90 % similarity level. The observation of varied IS6110-associated banding patterns indicates that an outbreak of drug-resistant tuberculosis did not occur in this area.Keywords
This publication has 37 references indexed in Scilit:
- Mapping and sequencing of mutations in the Escherichia colirpoB gene that lead to rifampicin resistancePublished by Elsevier ,2004
- Molecular Characterization of Rifampin-Resistant Isolates of Mycobacterium tuberculosis from Hungary by DNA Sequencing and the Line Probe AssayJournal of Clinical Microbiology, 2001
- Frequency of rpoB Mutations Inside and Outside the Cluster I Region in Rifampin-Resistant Clinical Mycobacterium tuberculosis IsolatesJournal of Clinical Microbiology, 2001
- Mutations in the Beginning of the rpoB Gene Can Induce Resistance to Rifamycins in both Helicobacter pylori and Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2000
- Global Burden of TuberculosisJAMA, 1999
- Laboratory contamination of Mycobacterium tuberculosis cultures.American Journal of Respiratory and Critical Care Medicine, 1995
- Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and RifampinNew England Journal of Medicine, 1993
- An Outbreak of Multidrug-Resistant Tuberculosis among Hospitalized Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1992
- IS6110: Conservation of sequence in the Mycobacterium tuberculosis complex and its utilization in DNA fingerprintingMolecular and Cellular Probes, 1991
- Permeability Barrier to Rifampin in MycobacteriaAntimicrobial Agents and Chemotherapy, 1977